Medication errors in the older people population

Mira, José Joaquín

doi:10.1080/17512433.2019.1615442

Cited by 21 publications

(15 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These errors might result in significant damage requiring a new pharmaceutical treatment, hospitalization, comorbidities, kidney damage, or even death in certain situations. 6 …”

Section: Introductionmentioning

confidence: 99%

Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria

Abukhalil¹,

Al-Imam²,

Yaghmour³

et al. 2022

CIA

View full text Add to dashboard Cite

Background: Elderly patients suffer from chronic diseases and are prone to polypharmacy and potentially inappropriate prescribing (PIP). This study aimed to identify potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) among elderly patients in a tertiary care hospital setting and to estimate the prevalence of polypharmacy. Methods: This multicenter retrospective observational study reviewed patient data from two major Palestinian hospitals. The collected data included patient demographics, comorbidities, and medications administered during hospitalization and discharge. The study included 247 patients aged ≥ 65 years hospitalized between January 2019 and December 2019. The STOPP/START criteria version 2 was used to identify the prevalence of PIMs and PPOs. Clinical pharmacists verified the data, and SPSS was used for data analysis. Descriptive statistics, one-tailed bivariate correlations, and Pearson's test were applied to the variables of interest to examine their association with the STOPP/START criteria. Results: A total of 247 patients were included in the study, and 50.2% were females. As a result, 165 (66.8%) participants were identified with PIPs, including 30 patients with PPOs, 91 with PIMs, and 44 with both. Furthermore, the prevalence of PIP during hospitalization and discharge was 56.29% and 64.39%, respectively. Polypharmacy (5-9 medications) was 44.5% and 52.1% during hospitalization and discharge, respectively, and excessive polypharmacy (ten medications or more) was 33.6% and 16.4% during hospitalization and discharge, respectively. Moreover, 47.3% of the patients had a comorbidity index of ≥ 5. Conclusion:This study identified a high prevalence of PIPs among elderly patients during hospital admission and discharge. In addition, more than half of the geriatric patients in this study had PIP and a high prevalence of polypharmacy. Therefore, this study emphasizes the importance of adapting evidence-based tools, such as the STOPP/START criteria, to optimize patient medication therapy and guide prescribers in identifying and resolving PIMs and PPOs.

show abstract

“…These errors might result in significant damage requiring a new pharmaceutical treatment, hospitalization, comorbidities, kidney damage, or even death in certain situations. 6 …”

Section: Introductionmentioning

confidence: 99%

Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria

Abukhalil¹,

Al-Imam²,

Yaghmour³

et al. 2022

CIA

View full text Add to dashboard Cite

show abstract

“…8 The probability of medical errors caused by health care professionals and patients increase with polypharmacy. 9,10 Prescription and monitoring errors were most common and reported in a range of 28-42% among polymedicated and aged patients in different health care settings. 11 The epidemiology of medication errors and related adverse events (AEs) was investigated by a systematic review of six international databases by Assiri et al (2018).…”

Section: Introductionmentioning

confidence: 99%

“…15 Beers criteria provide evidence-based recommendations on medications that health care providers (HCPs) should pay attention to, as these medications are probably not the most appropriate, safest or the best choice for older adults of 65 years and above. 9 The criteria identify five categories of PIMs: (1) independent of diagnosis or condition, (2) considering drug-disease/ syndrome interaction, (3) lack of evidence on benefit vs. risk, i.e., drugs to be used with caution, (4) clinically significant drug-drug interaction, and (5) require renal dose adjustment in case of impaired renal function; creatinine clearance (CrCl) category 9. The 2019 version has made some significant changes, additions and removals from the basic categories, making it more suitable for older patients.…”

Section: Introductionmentioning

confidence: 99%

Awareness of Beers criteria and potentially inappropriate medications among physicians and pharmacists in Palestine

Abukhalil

Shaloudi

Shamasneh

et al. 2021

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background: The American Geriatric Society Beers criteria comprise a screening tool to identify potentially inappropriate medications (PIMs) and guide healthcare providers (HCPs) in prescribing, dispensing, and recommending appropriate medications. The extent of awareness about PIMs and geriatric medicine among HCPs needs to be assessed. Therefore, this study aimed to examine the level of awareness regarding PIMs and Beers criteria among HCPs in Palestine. Method: This was a cross-sectional study conducted using a self-administered 20-item questionnaire involving physicians and pharmacists in Palestine. Ten clinical vignettes presenting different medical statuses in the elderly necessitating appropriate prescription advice were used to assess awareness on geriatric medication. Results: A total of 306 participants, including 116 physicians and 190 pharmacists, participated in the study. 34.0% of the participants had poor awareness, 30.1% had average and 23.2% participants had good awareness about PIMs in the elderly. Only a small percentage of participants had very poor or very good awareness (6.9% vs. 5.9%, respectively) with no difference in the results in terms of profession. There was a significant relationship between the familiarity with Beers criteria and the level of awareness. Finally, participants perceived drug-drug interactions as a major barrier to appropriate prescribing. Conclusion:The majority of participating HCPs had a low level of awareness, and a close proportion had moderate awareness on PIMs and Beers criteria. Consequently, there is a need to increase HCP's awareness of medication use in the elderly. Continued education and training in geriatric pharmacotherapy may be valuable.

show abstract

“…In addition, the clients felt that the use of the robot increased their sense of safety through proper management of medication therapy because they did not have to remember the time of taking medications. Older clients have a lot of medications in use and medical errors cause serious consequences for their health and well-being and are the leading cause of hospitalisation and death in this population [50]. The organisational consequences of medication errors enhance healthcare costs [7].…”

Section: Discussionmentioning

confidence: 99%

Older home care clients' experiences of digitalisation: A qualitative study of experiences of the use of robot for medicines management

Turjamaa

Vaismoradi

Kangasniemi³

2022

Scandinavian Caring Sciences

View full text Add to dashboard Cite

Background Home‐living older people with multiple medications are a key target group for medication robots. However, our understanding of how robots for medicines management work in older people's daily lives is limited. Aim The aim of this study was to describe older home care clients' experiences of the implementation and use of a robot for medicines management at home. Design A qualitative interview study. Methods Data were collected during spring and autumn 2021 using semi‐structured individual interviews with older home care clients (n = 38). The data were analysed using inductive content analysis. Results The older home care clients had positive experiences with the use of technology for the medication process, but they also faced challenges in their daily life activities. Implementation and use of the robot required open‐mindedness, satisfaction with the implementation, and the opportunity to practice the use of the robot with a nurse. However, the current design and size of the robot for medicines management in home care still need development, given that our research participants did not feel included in the robot development process. Conclusion The use of digital solutions will increase older people's home care. Therefore, there is a need to deepen our understanding of the implementation and use of digital solutions to prevent digital challenges and to provide a more comprehensive picture of this phenomenon. In addition, research focusing on whether the use of the robot affects medication administration incidents and medication adherence should be conducted to improve the safety of medicines management.

show abstract

Medication errors in the older people population

Cited by 21 publications

References 39 publications

Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria

Evaluating Inappropriate Medication Prescribing Among Elderly Patients in Palestine Using the STOPP/ START Criteria

Awareness of Beers criteria and potentially inappropriate medications among physicians and pharmacists in Palestine

Older home care clients' experiences of digitalisation: A qualitative study of experiences of the use of robot for medicines management

Contact Info

Product

Resources

About